Dexamethasone Sodium Phosphate NDC 63323-506

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-506Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0506Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-506-01	63323050601	25 VIAL in 1 TRAY (63323-506-01) / 1 mL in 1 VIAL (63323-506-00)Marketed from May 29, 2003
63323-506-13	63323050613	25 VIAL in 1 TRAY (63323-506-13) / 1 mL in 1 VIAL (63323-506-03)Marketed from Jan 6, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dexamethasone Sodium Phosphate
Generic name (nonproprietary): dexamethasone sodium phosphate
Active ingredients: Dexamethasone sodium phosphate — 10 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040491
Marketing start: May 29, 2003
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 63323-506_2ce90eb7-067d-4f1c-9184-c250e387e533SPL ID 2ce90eb7-067d-4f1c-9184-c250e387e533SPL set ID cca2c160-9188-48e8-9505-49a52388dcb7RxCUI 309696, 1812079UNII AI9376Y64PUPC 0363323506001, 0363323516017, 0363323506032
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323050601 followed by a unit qualifier and the quantity

Package 63323-0506-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 30, 2026.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040491

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040491
Product	Strength	Form · route	Labeler	Product NDC
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Sportpharm LLC	85766-071
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Sportpharm LLC	85766-186